Louisiana 2018 Regular Session

Louisiana Senate Bill SB189

Introduced
2/28/18  
Introduced
2/28/18  
Refer
2/28/18  
Refer
3/12/18  
Refer
3/12/18  
Report Pass
3/21/18  

Caption

Provides relative to electronic prescribing of noncontrolled legend drugs. (8/1/18)

Impact

The implementation of SB 189 is expected to significantly streamline the prescription process for noncontrolled legend drugs, thereby reducing errors associated with handwritten prescriptions and improving overall patient safety. By legislating electronic prescriptions, Louisiana aligns itself with broader trends in healthcare technology, potentially leading to enhanced communication between healthcare providers and pharmacists. This law could also pave the way for future legislation regarding the electronic prescription of controlled substances, contingent upon federal regulations being established by the Drug Enforcement Agency.

Summary

Senate Bill 189, also known as the Electronic Prescribing of Noncontrolled Legend Drugs Bill, aims to enhance the process of prescribing noncontrolled medications through electronic means. The legislation mandates specific requirements for electronic prescriptions, including necessary patient and prescription information to be securely transmitted to pharmacies. It is designed to improve the efficiency and security of medication prescriptions by requiring electronic signatures, date stamps, and internal identifiers for both prescribers and pharmacies, which is an important step towards modernizing prescription practices in healthcare.

Sentiment

The sentiment surrounding SB 189 is generally positive among healthcare providers and organizations advocating for advancements in health technology. Proponents argue that moving towards electronic prescriptions enhances the quality of care and decreases the administrative burden on medical professionals. However, there may still be reservations regarding the technology's accessibility and implications for smaller practices or those in rural areas, which could be less equipped to handle electronic systems effectively.

Contention

While SB 189 is primarily viewed as a forward-thinking initiative, discussions may arise regarding the potential challenges it presents for implementation, particularly concerning initial costs and training for medical staff. There is also the concern of data security and the protection of patient information within electronic systems. Addressing these issues is crucial for ensuring that the benefits of such legislation can be fully realized without compromising patient confidentiality or the operational capabilities of healthcare providers.

Companion Bills

No companion bills found.

Previously Filed As

LA SB477

Provides for electronic prescribing of noncontrolled legend drugs. (8/1/18)

LA SB368

Provides relative to mandatory use of electronic prescriptions. (8/1/18)

LA SB528

Provides relative to physician assistants. (8/1/18)

LA SB241

Provides relative to pharmacist communication with patients. (8/1/18)

LA SB300

Provides relative to tasks performed by direct service workers. (8/1/18)

LA SB166

Provides relative to physician assistants. (8/1/19)

LA SB223

Allows the use of electronic prescribing. (gov sig)

LA SB87

Provides relative to the electronic filing of documents. (8/1/18)

LA SB282

Provides relative to prescription drug pricing. (8/1/18) (EN NO IMPACT See Note)

LA SB90

Provides relative to a voluntary nonopioid directive form. (8/1/18) (EN SEE FISC NOTE SG RV See Note)

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

TX HB2174

Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.

TX SB1233

Relating to controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.